These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 11934715)

  • 1. Acute effects of aerosolized S-nitrosoglutathione in cystic fibrosis.
    Snyder AH; McPherson ME; Hunt JF; Johnson M; Stamler JS; Gaston B
    Am J Respir Crit Care Med; 2002 Apr; 165(7):922-6. PubMed ID: 11934715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhaled L-arginine improves exhaled nitric oxide and pulmonary function in patients with cystic fibrosis.
    Grasemann H; Kurtz F; Ratjen F
    Am J Respir Crit Care Med; 2006 Jul; 174(2):208-12. PubMed ID: 16627863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. S-nitrosoglutathione increases cystic fibrosis transmembrane regulator maturation.
    Zaman K; McPherson M; Vaughan J; Hunt J; Mendes F; Gaston B; Palmer LA
    Biochem Biophys Res Commun; 2001 Jun; 284(1):65-70. PubMed ID: 11374871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and tolerability of denufosol tetrasodium inhalation solution, a novel P2Y2 receptor agonist: results of a phase 1/phase 2 multicenter study in mild to moderate cystic fibrosis.
    Deterding R; Retsch-Bogart G; Milgram L; Gibson R; Daines C; Zeitlin PL; Milla C; Marshall B; Lavange L; Engels J; Mathews D; Gorden J; Schaberg A; Williams J; Ramsey B;
    Pediatr Pulmonol; 2005 Apr; 39(4):339-48. PubMed ID: 15704203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of S-nitrosoglutathione and L-cysteine on chloride efflux from cystic fibrosis airway epithelial cells.
    Servetnyk Z; Jiang S; Hjelte L; Gaston B; Roomans GM; Dragomir A
    Exp Mol Pathol; 2011 Feb; 90(1):79-83. PubMed ID: 20965165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute and long-term amiloride inhalation in cystic fibrosis lung disease. A rational approach to cystic fibrosis therapy.
    App EM; King M; Helfesrieder R; Köhler D; Matthys H
    Am Rev Respir Dis; 1990 Mar; 141(3):605-12. PubMed ID: 2310093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dornase alpha and exhaled NO in cystic fibrosis.
    Grasemann H; Lax H; Treseler JW; Colin AA
    Pediatr Pulmonol; 2004 Nov; 38(5):379-85. PubMed ID: 15390350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of rhDNase on airflow obstruction and mucociliary clearance in cystic fibrosis.
    Laube BL; Auci RM; Shields DE; Christiansen DH; Lucas MK; Fuchs HJ; Rosenstein BJ
    Am J Respir Crit Care Med; 1996 Feb; 153(2):752-60. PubMed ID: 8564129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aerosolized recombinant human DNase in hospitalized cystic fibrosis patients with acute pulmonary exacerbations.
    Wilmott RW; Amin RS; Colin AA; DeVault A; Dozor AJ; Eigen H; Johnson C; Lester LA; McCoy K; McKean LP; Moss R; Nash ML; Jue CP; Regelmann W; Stokes DC; Fuchs HJ
    Am J Respir Crit Care Med; 1996 Jun; 153(6 Pt 1):1914-7. PubMed ID: 8665055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aerosolized amiloride: dose effect on nasal bioelectric properties, pharmacokinetics, and effect on sputum expectoration in patients with cystic fibrosis.
    Hofmann T; Senier I; Bittner P; Hüls G; Schwandt HJ; Lindemann H
    J Aerosol Med; 1997; 10(2):147-58. PubMed ID: 10168532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peripheral airway involvement in CF and asthma compared by inert gas washout.
    Gustafsson PM
    Pediatr Pulmonol; 2007 Feb; 42(2):168-76. PubMed ID: 17186546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A pilot study of aerosolized amiloride for the treatment of lung disease in cystic fibrosis.
    Knowles MR; Church NL; Waltner WE; Yankaskas JR; Gilligan P; King M; Edwards LJ; Helms RW; Boucher RC
    N Engl J Med; 1990 Apr; 322(17):1189-94. PubMed ID: 2157983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. The Pulmozyme Study Group.
    Fuchs HJ; Borowitz DS; Christiansen DH; Morris EM; Nash ML; Ramsey BW; Rosenstein BJ; Smith AL; Wohl ME
    N Engl J Med; 1994 Sep; 331(10):637-42. PubMed ID: 7503821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. γ-Glutamyltransferase catabolism of S-nitrosoglutathione modulates IL-8 expression in cystic fibrosis bronchial epithelial cells.
    Corti A; Bergamini G; Menegazzi M; Piaggi S; Bramanti E; Scataglini I; Cianchetti S; Paggiaro P; Melotti P; Pompella A
    Free Radic Biol Med; 2013 Dec; 65():360-370. PubMed ID: 23820266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The clinical effect and the effect on the ciliary motility of oral N-acetylcysteine in patients with cystic fibrosis and primary ciliary dyskinesia.
    Stafanger G; Garne S; Howitz P; Morkassel E; Koch C
    Eur Respir J; 1988 Feb; 1(2):161-7. PubMed ID: 3282911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A multicenter, randomized, double-blind, placebo-controlled trial to evaluate the metabolic and respiratory effects of growth hormone in children with cystic fibrosis.
    Schnabel D; Grasemann C; Staab D; Wollmann H; Ratjen F;
    Pediatrics; 2007 Jun; 119(6):e1230-8. PubMed ID: 17545356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short-term efficacy of ultrasonically nebulized hypertonic saline in cystic fibrosis.
    Eng PA; Morton J; Douglass JA; Riedler J; Wilson J; Robertson CF
    Pediatr Pulmonol; 1996 Feb; 21(2):77-83. PubMed ID: 8882210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral L-arginine supplementation in cystic fibrosis patients: a placebo-controlled study.
    Grasemann H; Grasemann C; Kurtz F; Tietze-Schillings G; Vester U; Ratjen F
    Eur Respir J; 2005 Jan; 25(1):62-8. PubMed ID: 15640324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized controlled trial of inhaled L-arginine in patients with cystic fibrosis.
    Grasemann H; Tullis E; Ratjen F
    J Cyst Fibros; 2013 Sep; 12(5):468-74. PubMed ID: 23333044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low levels of exhaled nitric oxide are associated with impaired lung function in cystic fibrosis.
    Keen C; Gustafsson P; Lindblad A; Wennergren G; Olin AC
    Pediatr Pulmonol; 2010 Mar; 45(3):241-8. PubMed ID: 20146368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.